These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 7679407

  • 1. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR, Underwood LE, Baxter RC, Clemmons DR.
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [Abstract] [Full Text] [Related]

  • 2. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR, Smith-Banks A, Underwood LE.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [Abstract] [Full Text] [Related]

  • 3. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T, Wolthers T, Jensen SA, Møller N, Jørgensen JO, Tygstrup N, Orskov H, Vilstrup H.
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [Abstract] [Full Text] [Related]

  • 4. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
    Lieberman SA, Butterfield GE, Harrison D, Hoffman AR.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
    [Abstract] [Full Text] [Related]

  • 5. Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance.
    Clemmons DR.
    Horm Res; 1993 Feb; 40(1-3):62-7. PubMed ID: 8300052
    [Abstract] [Full Text] [Related]

  • 6. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
    Murphy MG, Plunkett LM, Gertz BJ, He W, Wittreich J, Polvino WM, Clemmons DR.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
    [Abstract] [Full Text] [Related]

  • 7. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
    Snyder DK, Clemmons DR, Underwood LE.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
    [Abstract] [Full Text] [Related]

  • 8. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC, Underwood LE, Celniker A, Clemmons DR.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [Abstract] [Full Text] [Related]

  • 9. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK, Clemmons DR, Underwood LE.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [Abstract] [Full Text] [Related]

  • 10. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent.
    Snyder DK, Underwood LE, Clemmons DR.
    Am J Clin Nutr; 1990 Sep; 52(3):431-7. PubMed ID: 2203249
    [Abstract] [Full Text] [Related]

  • 11. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC, Hinton PS, Yang H, Unterman TG, Ney DM.
    JPEN J Parenter Enteral Nutr; 1996 Sep; 20(3):171-7. PubMed ID: 8776688
    [Abstract] [Full Text] [Related]

  • 13. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.
    Mauras N, Haymond MW.
    Pediatr Nephrol; 1996 Jun; 10(3):318-23. PubMed ID: 8792396
    [Abstract] [Full Text] [Related]

  • 14. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
    Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG.
    Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
    [Abstract] [Full Text] [Related]

  • 15. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF, Hein AN, Miller JA, Hintz RL, Rosenfeld RG.
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [Abstract] [Full Text] [Related]

  • 16. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
    Pascual M, Larralde J, Martínez JA.
    Growth Dev Aging; 1995 Jan; 59(4):181-91. PubMed ID: 8770610
    [Abstract] [Full Text] [Related]

  • 17. Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition.
    Ney DM.
    JPEN J Parenter Enteral Nutr; 1999 Jan; 23(6 Suppl):S184-9. PubMed ID: 10571453
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury.
    Inaba T, Saito H, Fukushima R, Hashiguchi Y, Lin MT, Inoue T, Fukatsu K, Muto T, Oka T, Takenaka A, Takahashi S, Noguchi T.
    JPEN J Parenter Enteral Nutr; 1997 Jan; 21(2):55-62. PubMed ID: 9084006
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D, Walker JL, Adam E, Moatsstaats B, Mulumba N, Ketelslegers JM, Underwood LE.
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [Abstract] [Full Text] [Related]

  • 20. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA, Chin E, Bondy CA.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.